MENU
BCRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BioCryst Pharmaceuticals (BCRX) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

BCRX is expected to report earnings to fall 3.14% to -6 cents per share on February 19

BioCryst Pharmaceuticals BCRX Stock Earnings Reports
Q4'24
Est.
$-0.07
Q3'24
Est.
$-0.07
Q2'24
Beat
by $0.11
Q1'24
Beat
by $0.04
Q4'23
Missed
by $0.03
The last earnings report on November 04 showed earnings per share of -7 cents, meeting the estimate of -7 cents. With 745.44K shares outstanding, the current market capitalization sits at 1.58B.
View a ticker or compare two or three
BCRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of small molecule pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4505 Emperor Boulevard
Phone
+1 919 859-1302
Employees
536
Web
https://www.biocryst.com